Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:GEVO NYSEAMERICAN:KULR NASDAQ:LUCD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$2.76-0.7%$2.72$2.15▼$22.59$20.73M-0.45214,508 shs21,314 shsGEVOGevo$1.22-6.2%$1.35$0.48▼$3.39$311.43M2.672.71 million shs3.44 million shsKULRKULR Technology Group$5.25-4.4%$7.30$1.60▼$43.92$209.72M2.122.54 million shs1.25 million shsLUCDLucid Diagnostics$1.00+2.2%$1.20$0.72▼$1.80$105.87M1.21984,937 shs725,262 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies+0.18%-9.06%+7.81%+21.59%-87.16%GEVOGevo-6.15%-17.01%-13.48%+15.09%+109.98%KULRKULR Technology Group-4.37%-18.60%-20.09%-50.66%+135.55%LUCDLucid Diagnostics+2.19%-9.91%-4.76%-22.18%+25.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALURAllurion Technologies2.1567 of 5 stars3.53.00.00.00.61.70.6GEVOGevo1.4188 of 5 stars3.30.00.00.01.10.81.3KULRKULR Technology Group1.4967 of 5 stars3.52.00.00.00.00.80.6LUCDLucid Diagnostics2.728 of 5 stars3.63.00.00.02.31.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 3.00Buy$22.83727.29% UpsideGEVOGevo 2.50Moderate Buy$7.58520.90% UpsideKULRKULR Technology Group 3.00Buy$40.00661.90% UpsideLUCDLucid Diagnostics 3.20Buy$3.55255.00% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, LUCD, KULR, and GEVO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.006/6/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.50 ➝ $7.755/30/2025GEVOGevoHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.005/15/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.005/14/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$32.11M0.64N/AN/A($30.08) per share-0.09GEVOGevo$16.92M17.27N/AN/A$2.04 per share0.60KULRKULR Technology Group$10.74M18.67N/AN/A$1.68 per share3.13LUCDLucid Diagnostics$4.35M24.87N/AN/A($0.78) per share-1.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$26.15M-$12.50N/AN/AN/A-86.05%N/A-41.49%8/12/2025 (Estimated)GEVOGevo-$78.64M-$0.36N/AN/AN/A-193.87%-16.41%-13.13%8/11/2025 (Estimated)KULRKULR Technology Group-$17.52M-$0.12N/AN/AN/A-273.85%-56.07%-48.50%8/11/2025 (Estimated)LUCDLucid Diagnostics-$45.53M-$1.34N/AN/AN/A-1,699.86%N/A-124.27%8/13/2025 (Estimated)Latest ALUR, LUCD, KULR, and GEVO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025LUCDLucid Diagnostics-$0.09N/AN/AN/A$1.15 millionN/A8/12/2025Q2 2025ALURAllurion Technologies-$0.65N/AN/AN/A$6.20 millionN/A8/11/2025Q2 2025GEVOGevo-$0.06N/AN/AN/A$43.69 millionN/A8/11/2025Q2 2025KULRKULR Technology Group-$0.02N/AN/AN/A$3.45 millionN/A5/14/2025Q1 2025ALURAllurion Technologies-$1.53$0.43+$1.96$0.20$5.50 million$5.58 million5/13/2025Q1 2025GEVOGevo-$0.10-$0.09+$0.01-$0.09$22.19 million$29.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AKULRKULR Technology GroupN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.091.88GEVOGevo0.312.041.71KULRKULR Technology GroupN/A9.199.05LUCDLucid DiagnosticsN/A0.750.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%GEVOGevo35.17%KULRKULR Technology Group21.23%LUCDLucid Diagnostics74.01%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%GEVOGevo6.80%KULRKULR Technology Group11.21%LUCDLucid Diagnostics6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.46 million5.79 millionOptionableGEVOGevo100239.56 million223.27 millionOptionableKULRKULR Technology Group6038.20 million33.92 millionNot OptionableLUCDLucid Diagnostics70108.19 million100.83 millionNo DataALUR, LUCD, KULR, and GEVO HeadlinesRecent News About These CompaniesPAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025July 31 at 8:01 AM | prnewswire.comPAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleJuly 30 at 11:19 AM | finance.yahoo.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025July 30 at 8:01 AM | prnewswire.comLucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIGJuly 28, 2025 | msn.comSargent Investment Group LLC Sells 498,000 Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD)July 21, 2025 | marketbeat.comLucid says meeting scheduled to determine Medicare coverage for cancer testJuly 16, 2025 | msn.comLucid Diagnostics' (LUCD) Buy Rating Reaffirmed at Needham & Company LLCJuly 16, 2025 | marketbeat.comMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA TestJuly 16, 2025 | prnewswire.comLucid Diagnostics Inc News (LUCD) - Investing.comJuly 11, 2025 | investing.comLucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Buy" from AnalystsJuly 11, 2025 | marketbeat.comMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA TestJune 18, 2025 | prnewswire.comLucid Diagnostics to Join Russell 2000® and Russell 3000® IndexesMay 27, 2025 | prnewswire.comLucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potentialMay 21, 2025 | investing.comLucid Diagnostics Reports Increased Losses Amid Revenue DeclineMay 15, 2025 | tipranks.comEarnings call transcript: Lucid Diagnostics Q1 2025 highlights growth and strategic expansionMay 15, 2025 | investing.comPAVmed Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | prnewswire.comLucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call TranscriptMay 14, 2025 | seekingalpha.comLucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue EstimatesMay 14, 2025 | zacks.comLucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comWill Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should KnowMay 7, 2025 | zacks.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025April 30, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, LUCD, KULR, and GEVO Company DescriptionsAllurion Technologies NYSE:ALUR$2.76 -0.02 (-0.72%) Closing price 08/1/2025 03:58 PM EasternExtended Trading$2.77 +0.01 (+0.36%) As of 08/1/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Gevo NASDAQ:GEVO$1.22 -0.08 (-6.15%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.23 +0.01 (+0.41%) As of 08/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.KULR Technology Group NYSEAMERICAN:KULR$5.25 -0.24 (-4.37%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$5.34 +0.09 (+1.62%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, develops and commercializes thermal management technologies for electronics, batteries, and other components applications in the United States. It provides lithium-ion battery thermal runaway shields; automated battery cell screening and test systems; cellchecks; safecases; fiber thermal interface materials; phase change material heat sinks; internal short circuit devices; and CRUX cathodes. The company's technologies are used in electric vehicles, energy storage, battery recycling transportation, cloud computing, and 5G communication devices. It sells its products for applications, such as lithium-ion battery energy storage, electric vehicles, 5G communication, cloud computer infrastructure, consumer, and industrial devices. The company was formerly known as KT High-Tech Marketing Inc. and changed its name to KULR Technology Group, Inc. in August 2018. KULR Technology Group, Inc. was founded in 2013 and is based in San Diego, California.Lucid Diagnostics NASDAQ:LUCD$1.00 +0.02 (+2.19%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.02 +0.02 (+2.50%) As of 08/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
